Sumitomo Dainippon Pharma Co., Ltd. announced the appointment of Masayo Tada as representative Director, President and Chief Executive Officer, Executive Director, Drug Development from his current post Representative Director, President and Chief Executive Officer effective August 1, 2015; Nobuyuki Hara appointed as Executive Officer Deputy Executive Director, Drug Development from his current post Executive Officer, Executive Director, Drug Development effective August 1, 2015; Teruya Murata appointed as Director, Project Management from his current post Senior Advisor, Drug Development effective August 1, 2015; Hideo Tomiya appointed as Director, Data Science from his current post Deputy Executive Director, Drug Development, Director, Project Management effective August 1, 2015; and Kenji Shirakura appointed as Director, Clinical Operation from his current post Group Manager, Clinical Pharmacology Group, Clinical Research effective August 1, 2015.